Eisai and Biogen present promising lecanemab study results
Phase 3 research shows that Alzheimer’s disease treatment meets primary and secondary endpoints
Read More
Tag: Biogen
Lecanemab wins breakthrough therapy designation in Alzheimer’s disease
Designation is based on data from a Phase IIb study including 856 patients with mild Alzheimer’s disease
Read More
Biogen’s inherited eye disease gene therapy misses the mark in late-stage trial
Gene therapy was being evaluated for the treatment of the rare eye disease choroideremia
Read More
NICE broadens access to treatments for rheumatoid arthritis
New guidance enables earlier access to certain treatments, including biologics
Read More
Biogen, Eisai’s Alzheimer’s drug aducanumab makes history with US approval
First new treatment approved for Alzheimer’s disease in over a decade
Read More
Biogen partners with Ginkgo Bioworks on gene therapy manufacturing platform
Collaboration will aim to address challenge of timely and costly AAV-based vector manufacturing
Read More
Biogen’s inherited eye disease gene therapy misses primary endpoint
Company maintained, however, that the study showed ‘positive trends’ across a number of prespecified secondary endpoints
Read More
New subcutaneous formulation of Tysabri approved in UK
Multiple sclerosis treatment can now be administered subcutaneously or intravenously
Read More
EU nod for new formulation of Biogen’s Tysabri
A subcutaneous formulation will now be available to treat relapsing-remitting multiple sclerosis
Read More
EU authorises intramuscular administration of Biogen’s Plegridy for MS
New administration option for relapsing-remitting MS patients
Read More
Experimental motor neurone disease therapy shows early promise
Phase I/II study results demonstrate proof-of-concept and proof-of-biology of tofersen
Read More
Biogen launches digital self-help tool to support mental health in MS
ACT MySelf, was developed by Biogen in collaboration with people living with MS, the MS Trust, a team of MS specialist nurses and an MS clinical psychologist
Read More
- US study reveals interferon combinations cause lupus symptoms and affect treatment
- NIHR and TJBCM announce new funding initiative for novel brain tumour research
- UKHSA and ICL confirm variant which plays key role in global surge of Strep A infections
- Study reveals heart failure device could monitor patients and prevent hospitalisation
- MIT’s new MRI brain light-detecting technique could support brain cell studies
